G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)

Taiwan · Delayed Price · Currency is TWD

28.70

-0.50 (-1.71%)

Aug 4, 2026, 1:30 PM CST

G&E Herbal Biotechnology Financials Overview

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	261.21	309.13	249.03	181.44	64.61	24.57
Revenue Growth	-4.58%	24.13%	37.25%	180.84%	162.94%	-12.96%
Gross Profit	217.46	263.22	205.34	144.59	39.35	9.63
Operating Income	117.81	152.3	119.65	80.68	5.49	-19.56
Net Income	117.55	139.2	102.06	72.4	7.38	-19.88
Earnings Per Share	1.70	2.02	1.48	1.05	0.11	-0.29
EPS Growth	-1.31%	36.25%	40.82%	901.00%	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	421.7	430.31	408.87	312.92	205.95	108.88
Total Debt	0.65	0.87	1.75	1.98	-	-
Net Cash (Debt)	421.06	429.44	407.13	310.94	205.95	108.88
Net Cash Growth	-8.10%	5.48%	30.93%	50.98%	89.15%	-9.31%
Net Cash Per Share	6.10	6.23	5.91	4.51	2.99	1.58

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	11.31	70.18	134.68	113.48	99.96	-9.19
Capital Expenditures	-3.75	-3.2	-5.92	-5.52	-2.95	-1.77
Free Cash Flow	7.56	66.98	128.76	107.96	97.01	-10.96
Free Cash Flow Growth	-95.59%	-47.98%	19.26%	11.29%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	83.25%	85.15%	82.46%	79.69%	60.91%	39.17%
Operating Margin	45.10%	49.27%	48.04%	44.47%	8.49%	-79.61%
Pretax Margin	47.43%	51.24%	50.08%	49.88%	11.19%	-74.16%
Profit Margin	45.00%	45.03%	40.98%	39.90%	11.42%	-80.92%
FCF Margin	2.89%	21.67%	51.70%	59.50%	150.15%	-44.61%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Dividend Per Share	1.080	1.080	0.704	0.461
Dividend Per Share Growth	66.38%	53.43%	52.65%	-
Dividend Yield	3.70%	2.81%	1.52%	0.98%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	16.84	19.64	32.72	47.51	402.69	-
P/FCF Ratio	242.03	40.82	25.94	31.86	30.64	-
PS Ratio	7.00	8.84	13.41	18.96	46.01	63.43